Clearside Biomedical, Inc.
Clearside Biomedical, Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Jan 8, 2016Clearside Biomedical, Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Dec 8, 2025Removed from listing - SEC Form 25 filed.
SourceCLSD stopped trading
Dec 8, 2025CLSD is linked to Clearside Biomedical, Inc. and ended with final status "bankrupt".
Source
Entity Graph
Clearside Biomedical, Inc.issuedCLSD
CLSDlisted onNASDAQ
CLSDresulted inunknown
Source-Backed Claims
- Clearside Biomedical, Inc. filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code on November 25, 2025, in the United States Court for the District of Delaware, Case No. 25-12109.8-K
- On December 10, 2025, the Company filed a motion seeking approval of auction and bidding procedures in connection with a sale of all or substantially all of its assets.8-K
- The Company designated Health Ocean Limited, or its assignee, as the Stalking Horse Bidder in its sale process on December 17, 2025.8-K
- On December 19, 2025, the Court entered an order granting relief requested in the Bidding Procedures Motion, approving the Bidding Procedures and the designation of the Stalking Horse Bidder.8-K
- On December 23, 2025, the Company filed its monthly operating report with the Court for the period beginning November 23, 2025, and ending November 30, 2025.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.